Poonarva Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 11-01-2025
- Paid Up Capital ₹ 0.50 M
as on 11-01-2025
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -99.43%
(FY 2017)
- Profit 79.22%
(FY 2017)
- Ebitda 78.68%
(FY 2017)
- Net Worth -32.64%
(FY 2017)
- Total Assets 3.21%
(FY 2017)
About Poonarva Pharma
The Corporate was formerly known as Mahendra United Private Limited. The Company is engaged in the Metals And Minerals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Huliyuru Rani and Venkatesh Mahendra serve as directors at the Company.
- CIN/LLPIN
U74110KA2014PTC073522
- Company No.
073522
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 2014
- Date of AGM
28 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Tumkur, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Poonarva Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Huliyuru Rani  | Director | 10-Feb-2014 | Current |
| Venkatesh Mahendra | Additional Director | 13-Apr-2022 | Current |
Financial Performance of Poonarva Pharma.
Poonarva Pharma Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 99.43% decrease. The company also saw a substantial improvement in profitability, with a 79.22% increase in profit. The company's net worth observed a substantial decline by a decrease of 32.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Poonarva Pharma?
In 2017, Poonarva Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Poonarva Pharma?
Unlock and access historical data on people associated with Poonarva Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Poonarva Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Poonarva Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
